Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
48.3M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
1.98M
-
Shares change
-
-610K
-
Total reported value, excl. options
-
$607K
-
Value change
-
-$1.72M
-
Number of buys
-
17
-
Number of sells
-
-6
-
Price
-
$0.31
Significant Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q2 2025
31 filings reported holding INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value as of Q2 2025.
INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.98M shares
of 48.3M outstanding shares and own 4.09% of the company stock.
Largest 10 shareholders include SAPIENT CAPITAL LLC (977K shares), Sentinus, LLC (199K shares), BROWN ADVISORY INC (130K shares), Mesirow Financial Investment Management, Inc. (110K shares), GEODE CAPITAL MANAGEMENT, LLC (72.8K shares), Sigma Planning Corp (69.2K shares), Warberg Asset Management LLC (68.4K shares), JANE STREET GROUP, LLC (44.9K shares), VANGUARD GROUP INC (40.6K shares), and BLAIR WILLIAM & CO/IL (37.8K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.